Venrock

Venrock

Venrock logo
Type	Limited liability company
Industry	Venture Capital
Founded	1969
Headquarters	Palo Alto, California, United States
Products	Investments
Website	www.venrock.com

Venrock, a compound of "Venture" and "Rockefeller", is a pioneering venture capital firm formed in 1969 to build upon the successful investing activities of the Rockefeller family that began in the late 1930s. It has offices in Palo Alto, California; New York City; Cambridge, Massachusetts; and Israel.

History

The pioneering venture capitalist Laurance S. Rockefeller (1910–2004), was the fourth of the six children of John D. Rockefeller, Jr. In January 1946 he formed Rockefeller Brothers, Inc., one of the first postwar venture-capital operations, starting with a capitalization of $1.5 million. There were six partners in all, the five famed brothers and their sister, Abby. In August 1969, the firm became known as Venrock.

Over the years Laurance became well known as an investor in enterprises based on science and technology. His investment interests included the fields of aviation, aerospace, electronics, high temperature physics, composite materials, optics, lasers, data processing, thermionics, and nuclear power. It has invested more than $2.5 billion in more than 440 companies, resulting in 125 initial public offerings over the past 40 years.

Venrock focuses its investments on early-stage and start-up companies in information technology and emerging technologies. These include: Intel, Apple, AppNexus, StrataCom, Check Point Software, DoubleClick, 3Com Corporation, Mosaic, PGP, Itek, Digex, Media6Degrees, Shape Security, Smartling, Phoenix, Second Rotation (gazelle) and CTERA Networks. It also has a significant venture in the nascent nanotechnology field, with early funding of Nanosys and the nanotech division of Du Pont.^[1]

In the healthcare sector, with well-known and respected partners such as Bryan Roberts, Venrock has invested in athenahealth, HealthSouth Corporation, MedPartners, Inc., Castlight Health, Caliper Technologies Corporation, Centocor, Geron,^[2] Genetics Institute, Idec Pharmaceuticals Corporation, Illumina, Millennium Pharmaceuticals, Sirna Therapeutics, and Sugen.

See also

• Intel
• Apple
• DoubleClick
• Geron
• BioTime
• Illumina
• Digex
• Nanotechnology

References

Further reading

• Harr, John Ensor, and Peter J. Johnson. The Rockefeller Century: Three Generations of America's Greatest Family. New York: Charles Scribner's Sons, 1988.
• Winks, Robin W. Laurance S. Rockefeller: Catalyst for Conservation. New York: Island Press, 1997.

External links

• Company Website
• "Starting up in Silicon Valley: Long hours, forsaken Lives", The New York Times, February 6, 1984

Private equity and venture capital Basic investment types Buyout Venture Mezzanine Growth Secondaries Equity co-investment History History of private equity and venture capital Early history of private equity Private equity in the 1980s Private equity in the 1990s Private equity in the 2000s Terms and concepts Buyout Financial sponsor Management buyout Divisional buyout Buy–sell agreement Leveraged recapitalization Dividend recapitalization Venture Angel investor Business incubator Post-money valuation Pre-money valuation Seed money Startup company Venture capital financing Venture debt Venture round Structure Private equity firms and funds Limited partnership Limited liability company Carried interest Management fee Publicly traded private equity Business Development Company Venture capital trust Private investment in public equity (PIPE) Pledge fund Investors Corporations Institutional investors Pension funds Insurance companies Fund of funds Endowments Foundations Investment banks Merchant banks Commercial banks High-net-worth individuals Family offices Sovereign wealth funds Crowdfunding Related financial terms AUM Cap table Capital call Capital commitment Capital structure Distribution waterfall EBITDA Envy ratio High-yield debt IPO IRR Leverage M&A PME Taxation of private equity and hedge funds Undercapitalization Vintage year Private equity and venture capital investors Private equity firms Venture capital firms Angel investors Portfolio companies